KPV

KPV is a naturally occurring tripeptide representing the C-terminal sequence (residues 11-13) of alpha-melanocyte-stimulating hormone (alpha-MSH). Despite being derived from a melanocortin peptide, KPV exhibits potent anti-inflammatory activity through mechanisms independent of melanocortin receptor activation, making it unique among alpha-MSH-derived fragments.

The anti-inflammatory effects of KPV are mediated primarily through inhibition of NF-kB signaling, a master regulator of inflammatory gene expression. KPV enters cells and accumulates in the nucleus, where it directly interferes with NF-kB activation and reduces production of pro-inflammatory cytokines including IL-1beta, IL-6, and TNF-alpha.

Research has demonstrated particular efficacy in gastrointestinal inflammation models, where KPV promotes mucosal healing and reduces inflammatory damage in colitis. This has led to investigation of KPV for inflammatory bowel disease applications, with both systemic and local (oral) administration showing benefit.

The compound's favorable safety profile, cell-penetrating properties, and receptor-independent mechanism make it an attractive candidate for anti-inflammatory research. Its small size and oral stability distinguish it from larger melanocortin peptides that require parenteral administration.